The goal of this review is to evaluate the efficacy of commonly available dietary supplements in the treatment of hypertension, using the average blood pressure reduction achieved with the ...
Credit: Takeda. The approval was based on data from the phase 3 VISIBLE 2 trial. Results showed 48% of patients treated with vedolizumab SC were in clinical remission at week 52 compared with 34% ...
Merck revealed that its Phase III KEYLYNK-006 clinical trial, which tested a combination of Keytruda and Lynparza for the treatment of a subset of patients with metastatic nonsquamous non-small cell ...
A retired major general celebrated for his service in Afghanistan has said he was sent home from a tour early after sharing a bottle of champagne with colleagues. Charlie Herbert, who had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback